Vir Biotechnology
VIR
VIR
112 hedge funds and large institutions have $2.19B invested in Vir Biotechnology in 2020 Q2 according to their latest regulatory filings, with 63 funds opening new positions, 36 increasing their positions, 5 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
10.91% more ownership
Funds ownership: 34.49% → 45.4% (+11%)
3% less call options, than puts
Call options by funds: $9.94M | Put options by funds: $10.2M
Holders
112
Holding in Top 10
4
Calls
$9.94M
Puts
$10.2M
Top Buyers
| 1 | +$140M | |
| 2 | +$137M | |
| 3 | +$135M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$78.5M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$38.9M |
Top Sellers
| 1 | -$57.1M | |
| 2 | -$44.5M | |
| 3 | -$9.27M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$3.15M |
| 5 |
ICP
Indus Capital Partners
New York
|
-$3M |